AMUSSEN HUNSAKER ASSOCIATES LLC Viking Therapeutics, Inc. Transaction History

AMUSSEN HUNSAKER ASSOCIATES LLC portfolio value:

$65,000
portfolio value

AMUSSEN HUNSAKER ASSOCIATES LLC quarter portfolio value change:

-5.88%
quarter

Viking Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -4K $2.72 23.98K
Q2 2022 share 0.00% 0 shares -3K $2.89 23.98K
Q1 2022 share 0.00% 0 shares -38K $3 23.98K
Q4 2021 share 0.00% 0 shares -40K $4.64 23.98K
Q3 2021 share 0.00% 0 shares 5K $6.28 23.98K
Q2 2021 share Increase 0.00% 23.98K shares 145K $5.99 23.98K
Q1 2021 share Decrease -100.00% -19.03K shares -107K $6.33 0
Q4 2020 share 0.00% 0 shares -4K $5.63 19.03K
Q3 2020 share Increase +4.39% 800 shares -20K $5.82 19.03K
Q2 2020 share Decrease -29.53% -7.64K shares 10K $7.21 18.23K
Q1 2020 share 0.00% 0 shares -86K $4.68 25.87K
Q4 2019 share 0.00% 0 shares 29K $8.02 25.87K
Q3 2019 share 0.00% 0 shares -37K $6.88 25.87K
Q2 2019 share 0.00% 0 shares -42K $8.3 25.87K
Q1 2019 share 0.00% 0 shares 59K $9.94 25.87K
Q4 2018 share Decrease -10.85% -3.15K shares -120K $7.65 25.87K
Q3 2018 share Increase +136.94% 16.77K shares 202K $17.42 29.02K
Q2 2018 share Increase +1.66% 200 shares 63K $9.49 12.24K
Q1 2018 share Increase +11.78% 1.27K shares 9K $4.37 12.04K
Q4 2017 share Increase 0.00% 10.77K shares 44K $4.06 10.77K